US 12,144,838 B2
Composition for preventing, alleviating or treating neurodegenerative diseases, comprising Pediococcus inopinatus
Hak Jong Choi, Gwangju (KR); Nam Hee Kim, Jeollanam-do (KR); and Hyo Kyeong Park, Gwangju (KR)
Assigned to KOREA FOOD RESEARCH INSTITUTE, Jeollabuk-do (KR)
Appl. No. 17/423,183
Filed by KOREA FOOD RESEARCH INSTITUTE, Jeollabuk-do (KR)
PCT Filed Jan. 15, 2020, PCT No. PCT/KR2020/000754
§ 371(c)(1), (2) Date Jul. 15, 2021,
PCT Pub. No. WO2020/149647, PCT Pub. Date Jul. 23, 2020.
Claims priority of application No. 10-2019-0005270 (KR), filed on Jan. 15, 2019.
Prior Publication US 2022/0125862 A1, Apr. 28, 2022
Int. Cl. A61K 35/744 (2015.01); A23K 10/18 (2016.01); A23L 33/00 (2016.01); A23L 33/135 (2016.01); A61K 35/20 (2006.01); A61P 25/16 (2006.01)
CPC A61K 35/744 (2013.01) [A23K 10/18 (2016.05); A23L 33/135 (2016.08); A23L 33/40 (2016.08); A61K 35/20 (2013.01); A61P 25/16 (2018.01); A23V 2002/00 (2013.01); A23V 2400/423 (2023.08)] 9 Claims
OG exemplary drawing
 
1. A method for treating a neurodegenerative disease, comprising administering a composition comprising a therapeutically effective amount of Pediococcus inopinatus, or a culture thereof to a subject in need thereof,
wherein the Pediococcus inopinatus is Pediococcus inopinatus WIKIM27 deposited with an accession number KCCM12653P.